title: Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs.
abstract: A study was undertaken to determine the toxic effects of cisplatin, an antineoplastic agent, when administered immediately after a 1-hour saline diuresis. Four treatments with cisplatin (70 mg/m2 of body surface, q 3 wk) were administered IV to 6 healthy dogs over a 20-minute period after 0.9% NaCl (saline) solution was administered IV for 1 hour at a volume of 132 ml (kg)0.75. Each dog vomited at least once within 8 hours after each treatment was administered. Clinical status, body weight, and food consumption were normal throughout the 12-week study for 5 of the 6 dogs. The sixth dog developed acute renal failure and became acutely blind and deaf within 3 days after the fourth treatment with cisplatin. Serum electrolyte, creatinine, and urea nitrogen values remained within established normal limits in all dogs immediately prior to each treatment, and in 5 of 6 dogs evaluated 3 weeks after the final treatment. The serum creatinine value (3.3 mg/dl) obtained from the Beagle euthanatized 2 weeks after the fourth treatment was above established normal values. Despite normalcy for all but 1 of the creatinine values, serum creatinine concentration obtained 3 weeks after the final treatment with cisplatin was significantly (P = 0.0001) higher than pretreatment values. When compared with data from all other evaluation periods, significant decreases in glomerular filtration rate, as determined by exogenous (P less than or equal to 0.0001) and endogenous (P less than or equal to 0.0001) creatinine clearance testing, were identified 3 weeks after the fourth treatment with cisplatin.(ABSTRACT TRUNCATED AT 250 WORDS)
authors.affiliation: Department of Clinical Sciences, College of Veterinary Medicine and Biomedical Sciences, Colorado State University, Fort Collins 80523.
authors.forename: G K
authors.initials: GK
authors.lastname: Ogilvie
authors.forename: M J
authors.initials: MJ
authors.lastname: Fettman
authors.forename: V J
authors.initials: VJ
authors.lastname: Jameson
authors.forename: L M
authors.initials: LM
authors.lastname: Walters
authors.forename: M H
authors.initials: MH
authors.lastname: Lafferty
authors.forename: M F
authors.initials: MF
authors.lastname: Cooper
authors.forename: B E
authors.initials: BE
authors.lastname: Powers
authors.forename: P A
authors.initials: PA
authors.lastname: Ciekot
authors.forename: S W
authors.initials: SW
authors.lastname: Atwater
authors.forename: S J
authors.initials: SJ
authors.lastname: Withrow
mesh_terms: D058186:Acute Kidney Injury / Q000139:chemically induced / Q000517:prevention & control / Q000662:veterinary*; D000818:Animals; D001766:Blindness / Q000139:chemically induced / Q000662:veterinary; D001806:Blood Urea Nitrogen; D002945:Cisplatin / Q000633:toxicity*; D003404:Creatinine / Q000097:blood; D003638:Deafness / Q000139:chemically induced / Q000662:veterinary; D004231:Diuresis; D004283:Dog Diseases / Q000139:chemically induced* / Q000517:prevention & control; D004285:Dogs; D004573:Electrolytes / Q000097:blood; D005069:Evaluation Studies as Topic; D005919:Glomerular Filtration Rate; D007668:Kidney / Q000187:drug effects; D007958:Leukocyte Count / Q000662:veterinary; D008297:Male; D009504:Neutrophils / Q000187:drug effects; D012965:Sodium Chloride / Q000627:therapeutic use*; D014839:Vomiting / Q000139:chemically induced / Q000662:veterinary
chemical_list: D004573:Electrolytes; D012965:Sodium Chloride; D003404:Creatinine; D002945:Cisplatin